Enterprise Value
10.45B
Cash
425.6M
Avg Qtr Burn
-77.35M
Short % of Float
22.18%
Insider Ownership
8.38%
Institutional Own.
97.30%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|